← Back
Data updated: Mar 10, 2026
HEATHER
CardiovascularGastroenterologyInfectious Disease
HEATHER is a generic drug manufacturer focused on Cardiovascular, Gastroenterology, Infectious Disease.
1974
Since
18
Drugs
-
Trials
222
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
DOXYCYCLINE HYCLATE 2026-02-19
SULFAMETHOXAZOLE AND TRIMETHOPRIM 2026-02-10
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-01-26
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-18
Labeling
DOXYCYCLINE HYCLATE 2025-12-09
DOXYCYCLINE HYCLATE 2025-11-19
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 32%
1 drugs
Gastroenterology 32%
1 drugs
Infectious Disease 32%
1 drugs
Oncology 5%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Oncology, Infectious Disease, Gastroenterology
Merck big-pharma
Oncology, Infectious Disease, Cardiovascular
Baxter specialty
Infectious Disease, Cardiovascular, Oncology
Johnson & Johnson big-pharma
Oncology, Infectious Disease, Cardiovascular
WAYLIS THERAP big-pharma
Oncology, Cardiovascular, Infectious Disease, Gastroenterology
Active (2)
Discontinued (16)
SULFAMETHOXAZOLE AND TRIMETHOPRIM DIPHENHYDRAMINE HYDROCHLORIDE PREDNISONE DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE METHYLPREDNISOLONE METHYLTESTOSTERONE PREDNISOLONE METHOCARBAMOL TETRACYCLINE HYDROCHLORIDE CORTISONE ACETATE MEPROBAMATE DIMENHYDRINATE SULFISOXAZOLE PROPANTHELINE BROMIDE TRIPELENNAMINE HYDROCHLORIDE SULFAMETHOXAZOLE
Company Info
- First Approval
- 1974-03-21
- Latest
- 1974-12-11
- Applications
- 26